Document is current
Any future updates will be listed below
-
Authors
Dennaoui, Rayane
Rädler, Patrick D.
Wicker, Madison N.
Vistisen, Kerry
Ferraiuolo, Rosa‑Maria
Triplett, Aleata A.
Shrestha, Hridaya
Liner, Tessa A.
Manthey, Karoline C.
Rui, Hallgeir
Cardiff, Robert D.
Gunn, Teresa M.
Perou, Charles M.
Wagner, Kay-Uwe
-
Funding
Funding for this research was provided by:
Ruth L. Kirschstein National Research Service Award (CA009531, CA009476, CA009531)
South Carolina IDeA Networks of Biomedical Research Excellence (GM103499, GM103499)
U.S. Public Health Service (CA14876, CA219332)
Nebraska Cancer and Smoking Disease Research Program (LB506 2018-45)
- License Information
-
More Information
Article History
Received: 10 July 2024
Accepted: 20 March 2025
First Online: 7 July 2025
Declarations
:
: This work was conducted in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. We have complied with all relevant ethical regulations. The animal study protocols were approved by the Institutional Animal Care and Use Committee of the Nebraska Medical Center and Wayne State University.
: C.M.P. is an equity stockholder and consultant of BioClassifier LLC; C.M.P is also listed as an inventor on patent applications for the Breast PAM50 Subtyping assay. The other authors declare no competing interests.
